A detailed history of Freestone Capital Holdings, LLC transactions in Insulet Corp stock. As of the latest transaction made, Freestone Capital Holdings, LLC holds 1,059 shares of PODD stock, worth $276,568. This represents 0.01% of its overall portfolio holdings.

Number of Shares
1,059
Holding current value
$276,568
% of portfolio
0.01%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$180.69 - $239.01 $191,350 - $253,111
1,059 New
1,059 $246,000
Q1 2021

May 17, 2021

SELL
$235.95 - $293.05 $1,415 - $1,758
-6 Closed
0 $0
Q3 2020

Nov 06, 2020

BUY
$192.55 - $236.59 $1,155 - $1,419
6 New
6 $1,000

Others Institutions Holding PODD

About INSULET CORP


  • Ticker PODD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 69,403,600
  • Market Cap $18.1B
  • Description
  • Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes. It offers Omnipod System, a self-adhesive disposable tubeless Omnipod device that is worn on the body for up to three days at a time, as well as its wireless companion, the handheld personal diabetes manager. The company sel...
More about PODD
Track This Portfolio

Track Freestone Capital Holdings, LLC Portfolio

Follow Freestone Capital Holdings, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Freestone Capital Holdings, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Freestone Capital Holdings, LLC with notifications on news.